Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

2008491 citationsJournal Articlehybrid Open Access

Authors

NCT00175877.

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 68, Issue 6, pp. 797-804

Field-Weighted Citation Impact: 30.63